ArticleWorld journal of gastroenterology2016

Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12.

Christoph R Werner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.